NAGE.US Niagen Bioscience, Inc.

Consumer Defensive Life Sciences Tools & Services USA Stocks
2.07 USD
Close of Nov 15, 2026
1.97 7.12
Market cap
USD 164M
P/E
17.2x
P/B
1.96x
ROE
9.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is NAGE.US undervalued?

Graham number
Price2.07
Graham value1.68
Premium22.6%

NAGE.US trades 22.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Niagen Bioscience, Inc. fundamental analysis

No fundamental analysis for Niagen Bioscience, Inc. yet.

Niagen Bioscience, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Niagen Bioscience, Inc.

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingred…

Full company profile